Michael Keng
Impact in
- Hematology top 5%
- Hematopoietic Stem Cell Transplantation
- Acute Myeloid Leukemia Research
-
- Neutropenia and Cancer Infections
- CAR-T cell therapy research
Papers in
- Hematology 20
- Acute Myeloid Leukemia Research 12
- Chronic Myeloid Leukemia Treatments 5
- Oncology 19
- Neutropenia and Cancer Infections 12
- CAR-T cell therapy research 5
- Co-authors
- Mikkael A. Sekeres (7 shared papers)Firas El Chaer (10 shared papers)Amy Morris (14 shared papers)Karen K. Ballen (3 shared papers)Daniel Reed (14 shared papers)Kristen White (1 shared paper)David G. Maloney (1 shared paper)Barry E. Storer (1 shared paper)
- Journals
- Blood (14 papers)Journal of Clinical Oncology (9 papers)Current Hematologic Malignancy Reports (7 papers)Journal of Oncology Practice (3 papers)Cancer Management and Research (2 papers)
- Partner nations
- United StatesUgandaAustralia
In The Last Decade
Michael Keng
48 papers receiving 477 citations
Peers
Comparison fields: 5 of 70
- Hematology 140
- Oncology 173
- Clinical Biochemistry 31
- Public Health, Environmental and Occupational Health 87
- Immunology 58
Countries citing papers authored by Michael Keng
This map shows the geographic impact of Michael Keng's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael Keng with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael Keng more than expected).
Fields of papers citing papers by Michael Keng
This network shows the impact of papers produced by Michael Keng. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael Keng. The network helps show where Michael Keng may publish in the future.
Co-authors
The 25 scholars most cited alongside Michael Keng, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 55 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2003 | 83 | |
| 2 | 2020 | 50 | |
| 3 | 2015 | 50 | |
| 4 | 2013 | 47 | |
| 5 | 2017 | 32 | |
| 6 | 2007 | 18 | |
| 7 | 2015 | 18 | |
| 8 | 2019 | 16 | |
| 9 | 2018 | 15 | |
| 10 | 2022 | 14 | |
| 11 | 2019 | 11 | |
| 12 | 2021 | 11 | |
| 13 | 2019 | 10 | |
| 14 | A drug's life: the pathway to drug approval. | 2013 | 10 |
| 15 | 2020 | 9 | |
| 16 | 2022 | 8 | |
| 17 | 2022 | 8 | |
| 18 | 2024 | 8 | |
| 19 | 2020 | 7 | |
| 20 | 2023 | 6 |
About Michael Keng
Michael Keng is a scholar working on Hematology, Oncology, Public Health, Environmental and Occupational Health, Molecular Biology and Genetics, having authored 55 papers that have together received 489 indexed citations. Recurring topics across this work include Acute Lymphoblastic Leukemia research (15 papers), Acute Myeloid Leukemia Research (12 papers), Neutropenia and Cancer Infections (12 papers), CAR-T cell therapy research (5 papers), Chronic Myeloid Leukemia Treatments (5 papers), Chronic Lymphocytic Leukemia Research (5 papers), Economic and Financial Impacts of Cancer (4 papers) and Histone Deacetylase Inhibitors Research (4 papers). The work is most often cited by research in Hematology (140 citations), Oncology (173 citations), Clinical Biochemistry (31 citations), Public Health, Environmental and Occupational Health (87 citations) and Immunology (58 citations). Michael Keng has collaborated with scholars based in United States, Uganda and Australia. Frequent co-authors include Mikkael A. Sekeres, Firas El Chaer, Amy Morris, Karen K. Ballen, Daniel Reed, Kristen White, David G. Maloney, Barry E. Storer, Jan Storek and Monja A. Dawson. Their work appears in journals such as Blood, Journal of Clinical Oncology, Current Hematologic Malignancy Reports, Journal of Oncology Practice and Cancer Management and Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.